Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1.
doi: 10.1007/s00277-025-06494-9. Online ahead of print.

TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute myeloid leukemia

Xue Chen #  1 , Lili Yuan #  1 , Xiaoli Ma  1 , Fang Wang  1 , Yang Zhang  1 , Panxiang Cao  1 , Ping Wu  1 , Tong Wang  1 , Jiaqi Chen  1 , Xiaosu Zhou  2 , Hongxing Liu  3   4
Affiliations

TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute myeloid leukemia

Xue Chen et al. Ann Hematol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: Samples were obtained in accordance with the principles of the Declaration of Helsinki and the Chinese legislation for the protection of personal data and research on human samples. The study was approved by the Institutional Review Board and Ethical Committee of Hebei Yanda Lu Daopei Hospital. Consent for publication: Written informed for publication was obtained from the patient. Competing interests: The authors declare no competing interests.

References

    1. Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 36(7):1703–1719 - DOI - PubMed - PMC
    1. Arber DA, Orazi A, Hasserjian RP et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200–1228 - DOI - PubMed - PMC
    1. Umino K, Fujiwara SI, Ikeda T et al (2018) Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology 23(8):470–477 - DOI - PubMed
    1. Jackson CC, Medeiros LJ, Miranda RN (2010) 8p11 myeloproliferative syndrome: a review. Hum Pathol 41(4):461–476 - DOI - PubMed
    1. Strati P, Tang G, Duose DY et al (2018) Myeloid/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma 59(7):1672–1676 - DOI - PubMed

LinkOut - more resources